Workflow
Hitech Develop(600082)
icon
Search documents
600082大动作!筹划重大资产重组
Zhong Guo Ji Jin Bao· 2025-06-05 16:07
【导读】海泰发展拟现金收购知学云控股权,剑指新质生产力赛道 6月5日,以科技园区开发运营为主业的天津老牌国企海泰发展(证券代码:600082)披露了一则筹划重 大资产重组的提示性公告——其正筹划以现金方式收购知学云(北京)科技股份有限公司(以下简称知 学云)控股权。交易若成行,将标志着这家老牌国企正式向数字化、智能化的新质生产力领域进军。 根据相关规定,本次交易不涉及股票停牌,海泰发展将根据相关事项的进展情况,分阶段履行信息披露 义务;预计自本公告披露之日起6个月内,海泰发展将披露本次交易相关的预案或报告书(草案)。 筹划现金收购控股权 转型新质生产力 根据公告,本次交易的核心内容可概括为"现金收购+控股整合"两大关键词。海泰发展拟以现金方式购 买知学云部分股东持有的股权,交易完成后知学云将成为其控股子公司。 尽管交易价格及具体收购比例尚未最终确定,但经初步测算,本次交易预计构成《上市公司重大资产重 组管理办法》规定的重大资产重组。 从交易方式看,本次收购具有三个特征:其一,本次交易拟纯现金交易,不涉及发行股份;其二,不构 成关联交易,交易对方为知学云部分股东,最终名单尚待协商确定;其三,不会导致上市公司控制 ...
上市公司动态 | 兵器装备集团汽车业务分立,多家上市公司股东变更,美格智能披露港股上市进程
He Xun Cai Jing· 2025-06-05 15:24
Key Points - The China Ordnance Equipment Group has been approved to separate its automotive business into an independent central enterprise, with the State-owned Assets Supervision and Administration Commission (SASAC) taking on the role of investor [2] - Following the separation, companies such as Changan Automobile, Hunan Tianyan, and Dong'an Power will have their indirect controlling shareholders changed to the newly formed central enterprise, while the actual controllers remain unchanged [2] - MegSmart has received approval from its shareholders to issue H-shares and list on the Hong Kong Stock Exchange, with over two-thirds of the voting rights in favor [4] - Shenzhou Cell plans to raise up to 900 million yuan through a private placement to its controlling shareholder, Lhasa Ailike, for working capital [6] - Maipu Medical intends to acquire 100% of Yijie Medical through a combination of stock issuance and cash payment, which will enhance its capabilities in the field of interventional biomaterials [8] - Haitai Development is planning to acquire the controlling stake in Zhixueyun (Beijing) Technology Co., with the transaction potentially classified as a major asset restructuring [9] - A-share issuer Zhongyida has received an inquiry letter from the Shanghai Stock Exchange regarding its application for a private placement of shares [15] - ST Lingda's chairman and president Wang Mingsheng has resigned for personal reasons, with Jin Yongfeng elected as the new chairman [16] - Muyuan Foods reported a 26.93% year-on-year increase in sales revenue from commodity pigs in May, totaling 12.258 billion yuan [18] - Dongfeng Motor's May vehicle sales were 10,073 units, a decrease from the previous year's 11,615 units, with a cumulative decline of 14.45% for the first five months [19] - Inse Group plans to acquire 80% of the Zhizhe brand and raise up to 320.8 million yuan through a private placement to enhance its marketing capabilities [21] - FAW Fuwi will change its stock name to Fuwi Co., effective June 11, 2025, as part of its strategy to reduce reliance on a single customer [22] - COSCO Shipping Energy plans to register for the issuance of medium-term notes not exceeding 5 billion yuan [23] - Zhongtong Bus reported a 4.21% year-on-year decline in May sales, totaling 1,001 units, while cumulative sales for the year increased by 3.53% [24] - Taijing Technology's wholly-owned subsidiary Chongqing Jingxin plans to absorb and merge with another subsidiary, aiming to optimize resource allocation and reduce operational costs [25]
营收三连降后,海泰发展拟现金收购“学习平台”知学云 拓展第二增长曲线
Mei Ri Jing Ji Xin Wen· 2025-06-05 14:25
Core Viewpoint - HaiTai Development is planning to acquire a controlling stake in ZhiXueYun, an AI-based learning solutions provider, to enhance its business and create a second growth curve [1][6]. Group 1: Acquisition Details - HaiTai Development is in the process of negotiating the cash purchase of ZhiXueYun's controlling stake, with the exact transaction price and share acquisition ratio yet to be determined [1][3]. - The acquisition aims to secure control over ZhiXueYun, which will become a subsidiary of HaiTai Development upon completion of the transaction [3][6]. - The transaction is still in the planning stage, and no formal agreements have been signed, pending further negotiations and necessary approvals [3][4]. Group 2: ZhiXueYun Overview - ZhiXueYun focuses on providing AI-driven digital learning solutions, helping clients achieve scalable, intelligent, and personalized talent development [1][8]. - The company has developed a proprietary low-code PaaS platform and serves over 2,500 clients, with more than 30 million users and a market coverage exceeding 60% [8][9]. - Notable clients include major enterprises such as China Nuclear Group, China Mobile, and SAIC Group [9]. Group 3: HaiTai Development's Business Context - HaiTai Development primarily operates in industrial real estate development and has faced declining revenues for three consecutive years, with a reported revenue of 7.78 million yuan in Q1 2025, down 35.15% year-on-year [11]. - The company aims to diversify its business and enhance its core competitiveness through this acquisition, which aligns with the interests of its shareholders [6][11]. - As of Q1 2025, HaiTai Development had a cash balance of 418 million yuan, indicating its financial capacity to pursue this acquisition [11].
亚钾国际:监事彭志云因涉嫌内幕交易被立案调查;泽璟制药:签署注射用重组人促甲状腺激素独家市场推广服务协议丨公告精选
Group 1 - Yara International's supervisor Peng Zhiyun is under investigation for insider trading, which is unrelated to the company's daily operations [2] - The company is operating normally despite the investigation, and Peng has applied to resign from his position [2] Group 2 - Fulin Precision's subsidiary Jiangxi Shenghua signed a supplementary agreement with CATL to increase production capacity to 160,000 tons/year in Jiangxi and 200,000 tons/year in Sichuan [3] - The agreement ensures that CATL will prioritize its demand from Jiangxi Shenghua and commit to purchasing at least 80% of the promised capacity annually [3] - This partnership is expected to enhance the competitiveness and sustainability of Fulin Precision's lithium iron phosphate business [3] Group 3 - Zai Jian Pharmaceutical signed an exclusive market promotion service agreement for recombinant human thyroid-stimulating hormone injection with Merck's Swiss subsidiary, Ares Trading S.A. [3] - The agreement includes a maximum authorization fee of RMB 250 million, with an initial payment of RMB 50 million due within 30 working days after the agreement takes effect [3] - The product is currently in the drug registration application stage [3] Group 4 - Wenta Technology announced that its major shareholder, Wuxi Guolian Integrated Circuit Investment Center, plans to reduce its stake by up to 3%, equating to 37.34 million shares [4] - The reduction will occur between June 27, 2025, and September 26, 2025 [4] Group 5 - Sanofi Guojian's application for a new drug listing for a recombinant anti-IL-1β humanized monoclonal antibody injection has been accepted by the National Medical Products Administration [5] - The drug is intended for the treatment of acute gouty arthritis and has achieved primary efficacy endpoints in Phase III clinical trials [5] Group 6 - Shuyou Shen's product STSP-0601 has been included in the priority review list by the National Medical Products Administration [6] - The product is a Class 1 therapeutic biological product approved for clinical trials for hemophilia A or B patients [7] Group 7 - Ningbo Port expects to complete a container throughput of 4.53 million TEUs in May, representing a year-on-year increase of 7.1% [8] - Wens Foodstuff's pig sales revenue increased by 14.23% year-on-year in May [8] - Dongfeng Motor's cumulative vehicle sales from January to May were 59,859 units, a decrease of 14.45% year-on-year [8]
海泰发展拟以现金方式收购知学云控股权;闻泰科技股东拟减持不超3%公司股份|公告精选
Mei Ri Jing Ji Xin Wen· 2025-06-05 14:04
Group 1: Major Asset Restructuring - Haitai Development plans to acquire controlling stake in Zhixueyun (Beijing) Technology Co., Ltd. through cash payment, with transaction price and acquisition ratio to be further negotiated [1] - This transaction is expected to constitute a major asset restructuring upon completion, with Zhixueyun becoming a subsidiary of Haitai Development [1] Group 2: Share Acquisition - Maipu Medical has approved a plan to purchase 100% equity of Yijie Medical through a combination of issuing shares and cash payment, involving 10 transaction parties [2] Group 3: Shareholding Reduction - Wenta Technology's major shareholder, Wuxi Guolian, plans to reduce its stake by up to 3%, amounting to a maximum of 37.34 million shares [3] - Jingjin Electric's shareholders plan to collectively reduce their holdings by up to 3.25%, with specific reductions from various shareholders totaling 1.25 million shares [4] - Kaiwei Technology's major shareholder, Ganhua Science and Technology, intends to reduce its stake by up to 3% through both centralized bidding and block trading [5] Group 4: Stock Price Fluctuations - Nanhua Futures reported a 20% cumulative deviation in stock price over three trading days, confirming that there have been no significant changes in its business operations [7] - Yuyin Co. also experienced a 20% cumulative deviation in stock price, with no undisclosed significant matters affecting its operations [8] Group 5: Insider Trading Investigation - Yaqi International's supervisor, Peng Zhiyun, is under investigation for suspected insider trading, which is unrelated to the company's daily operations [6]
晚间公告丨6月5日这些公告有看头
Di Yi Cai Jing· 2025-06-05 10:10
6月5日晚间,沪深两市多家上市公司发布公告,以下是第一财经对一些重要公告的汇总,供投资者参 考。 【品大事】 海泰发展:拟以现金方式收购知学云控股权 预计构成重大资产重组 海泰发展公告称,公司正在筹划以现金方式购买知学云(北京)科技股份有限公司控股权,交易价格及 收购比例待进一步论证和协商。本次交易完成后,知学云将成为公司控股子公司。根据初步测算,本次 交易可能构成《上市公司重大资产重组管理办法》规定的重大资产重组。 舒泰神:注射用STSP-0601纳入优先审评程序 舒泰神公告称,子公司贝捷泰的产品注射用STSP-0601于5月26日被国家药品监督管理局药品审评中心 纳入拟优先审评品种公示名单。公示期满后,根据国家药品监督管理局药品审评中心网站信息公开显 示,于6月5日纳入优先审评品种名单,正式进入药品上市许可优先审评审批程序。 翠微股份:公司目前主营业务尚处于亏损状态 翠微股份发布股票交易异常波动公告,公司近年受零售行业市场环境、支付行业政策市场变化、以及子 公司当代商城中关村店闭店重建等因素的影响,零售业务和收单业务收入降幅较大,公司目前主营业务 尚处于亏损状态。 东方雨虹:公司及子公司获得政府补助113 ...
海泰发展(600082) - 天津海泰科技发展股份有限公司关于筹划重大资产重组的提示性公告
2025-06-05 09:15
关于筹划重大资产重组的提示性公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 天津海泰科技发展股份有限公司(以下简称"公司")正在筹划以现金方式 购买知学云(北京)科技股份有限公司(以下简称"知学云"、"标的公司")控 股权,交易价格及收购比例待进一步论证和协商。本次交易完成后,知学云将成为 公司控股子公司。 根据初步测算,本次交易可能构成《上市公司重大资产重组管理办法》规定 的重大资产重组。本次交易拟采用现金方式,不涉及公司发行股份,不构成关联交 易,也不会导致上市公司控制权的变更。 本次交易尚处于筹划阶段,交易双方尚未签署任何相关协议(保密协议除外), 交易价格、股权收购比例、业绩承诺等交易方案核心要素仍需进一步论证和协商, 尚需履行公司、标的公司及交易对方必要的内外部相关决策、审批程序。公司将根 据相关规定聘请证券服务机构开展工作,预计自本提示性公告披露之日起 6 个月内 披露本次交易相关的预案或报告书(草案)。本次交易尚存在较大不确定性,敬请 广大投资者注意投资风险。 证券代码:600082 证券简 ...
海泰发展: 天津海泰科技发展股份有限公司2024年年度股东会决议公告
Zheng Quan Zhi Xing· 2025-05-30 10:41
Meeting Details - The shareholders' meeting was held on May 30, 2025, at the company's conference room in Tianjin [1] - The attendance rate of ordinary shareholders and preferred shareholders with restored voting rights was 25.0262% [1] Voting Process - The meeting was convened by the board of directors and utilized a combination of on-site and online voting methods, presided over by Chairman Liu Chao [1] - The voting process complied with the Company Law and the company's articles of association [1] Proposal Review - All non-cumulative voting proposals were approved with significant support from shareholders, with the approval rates for A shares ranging from 99.3355% to 99.6012% [2][3] - The proposal to cancel the supervisory board and amend the articles of association was also passed with 99.6021% approval from A shares [2][3] Special Resolutions - Proposals 7 and 9, concerning the approval of the 2025 annual guarantee limit and the cancellation of the supervisory board, were special resolutions that received over two-thirds of the valid voting rights [3] Legal Compliance - The meeting's procedures were confirmed to be in compliance with Chinese laws, regulations, and the company's articles of association by the witnessing lawyers [3]
海泰发展(600082) - 天津海泰科技发展股份有限公司2024年年度股东会决议公告
2025-05-30 10:15
证券代码:600082 证券简称:海泰发展 公告编号:2025-012 天津海泰科技发展股份有限公司 2024年年度股东会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 本次会议是否有否决议案:无 一、会议召开和出席情况 (一)股东大会召开的时间:2025 年 5 月 30 日 (二)股东大会召开的地点:天津海泰科技发展股份有限公司会议室(天津新技术 产业园区华苑产业区海泰西路 18 号中南楼三层) (三)出席会议的普通股股东和恢复表决权的优先股股东及其持有股份情况: | 1、出席会议的股东和代理人人数 | 120 | | --- | --- | | 2、出席会议的股东所持有表决权的股份总数(股) | 161,698,720 | | 3、出席会议的股东所持有表决权股份数占公司有表决权股 | | | 份总数的比例(%) | 25.0262 | (四)表决方式是否符合《公司法》及《公司章程》的规定,大会主持情况等。 本次会议由公司董事会召集,采用现场投票和网络投票相结合的方式表决, 现场会议由董事长刘超先 ...
海泰发展(600082) - 《北京中伦文德(天津)律师事务所关于天津海泰科技发展股份有限公司2024年度股东会之法律意见书》
2025-05-30 10:15
中伦文德(天津)律师事务所 ZHONGLUN W&D (TIANJIN) LAW FIRM 中国|天津市南开区金融街中心融汇广场A座38层 58580759 TFI . 86-22- 58580758 滨海新区 新城西路 52号滨海合融街西区 WRA413 TEL: 022-658338 关于 天津海泰科技发展股份有限公司 2024 年度股东会之 法律意见书 2025 年 5 月 30 日 t 20 the 北京中伦文德(天津)律师事务所 法律意见书 北京中伦文德(天津)律师事务所 关于天津海泰科技发展股份有限公司 北京中伦文德(天津)律师事务所 2024年度股东会之法律意见书 致:天津海泰科技发展股份有限公司 北京中伦文德(天津)律师事务所(以下简称"本所")接受天津海泰科 技发展股份有限公司(以下简称"公司")的委托,指派律师(以下简称 "本所律师")列席公司2024年度股东会(以下简称"本次股东会").根据 《中华人民共和国公司法》(以下简称"《公司法》")、《中华人民共和 国证券法》、《上市公司股东会规则》、《上海证券交易所上市公司自 律监管指引第1号-规范运作》等中国现行法律、行政法规和规范性文件 ...